Navigation Links
GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2
Date:4/21/2009

NEW YORK, April 21 /PRNewswire/ -- GenVault, a leading provider of room-temperature biosample transport, storage and management technologies, announced the release today of GenConnect 3.2, the newest version of its software for complete biosample management. Highlights of the release include a strategic licensing model that enables GenConnect to be integrated seamlessly into third-party informatics offerings, as well as a new customer licensing model that enables scalable enterprise-wide deployment that can be centrally administered.

GenConnect 3.2 supports the tracking of individual samples -- with either GenVault's own GenTegra(TM) tubes for purified DNA stored at room temperature, or generic tubes and vials stored in the frozen state - throughout the storage, retrieval and transport lifecycle. All data associated with storage locations and samples can be batch-uploaded to the database with a single click, making GenConnect an ideal solution for enterprise sites that need to process thousands of sample aliquots per day.

"With its rich JAVA-based API, language-independent Web Services interface, and standardized flat-file import/export capabilities, GenConnect can be seamlessly integrated with any upstream or downstream informatics packages and databases. The latest example of this is the integration of GenConnect 3.2 to GenoLogics' Biomedical Informatics product suite, as a part of our continuing partnership with GenoLogics to enable turnkey solutions for clinical and discovery research," said Dr. Dipesh Risal, Senior Product Manager for Software at GenVault. "GenConnect's client-server architecture allows for enterprise-level multi-site deployments, enabling both inter- and intra-institution connectivity; further, strict and tiered access controls built into the software means that entire networks of end-users can be administered from a centralized location. With this release, we are also rolling out a simple yet scalable licensing model that enables our customers to start small, with the option to scale-up and add more users as they derive greater value from the software."

GenConnect can accommodate the full spectrum of storage units used in biobanking, from traditional containers such as freezers and liquid nitrogen tanks, to the space saving, energy-efficient room-temperature storage options provided by GenVault. Stringent QA controls are built into the software for all Project, Subject and Sample-level data entry.

About GenVault

GenVault is a Global provider of cutting-edge technologies, for the acquisition, transportation and storage of biospecimens at ambient temperature, in the dry-state. GenConnect software, used to manage these technologies, can also be used with traditional cryogenic systems to enable mixed-phase sample management.

GenVault's technologies are environmentally friendly, space efficient alternatives to traditional sample storage systems. They reduce the carbon footprint of labs and significantly reduce energy consumption.

GenVault's systems are currently empowering over 150 pharmaceutical companies, medical centers and academic research institutions to sustainably leverage the rapidly growing genomics industry.

For more information, visit http://www.genvault.com/.

Available Topic Expert: For information on the listed expert, click appropriate link.

Dipesh Risal

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87341

CONTACT: Bret Dash, 760-268-5242, bdash@genvault.com.


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
2. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
3. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
4. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
5. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
6. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
7. GenVault Expands Scientific Advisory Board
8. GenVault Corporation Launches GenTegra(TM) DNA
9. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
10. GenVault to Present at the BIOCOM Investor Conference
11. GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... COLORADO (PRWEB) , ... April 21, 2017 , ... ... Awards recognized outstanding manufactures in 10 categories with over 30 nominees and well ... in Manufacturing presented the new award and the event was hosted by CompanyWeek ...
(Date:4/21/2017)... ANAHEIM, California, and BELLINGHAM, Washington, USA (PRWEB) , ... ... ... of photonics technologies for sensing, imaging, and related applications were the focus of ... Defense and Commercial Sensing 2017 in Anaheim. , Sponsored by SPIE, ...
(Date:4/21/2017)... ... ... Frederick Innovative Technology Center, Inc. (FITCI), a business incubator ... a $77,518 grant from the Rural Maryland Council (RMC) to support refurbishment of ... incubator. A non-profit corporation, FITCI is a public-private partnership of the governments of ...
(Date:4/20/2017)... INDIANAPOLIS , April 20, 2017  Eli Lilly ... Phase 2 data evaluating galcanezumab for the prevention of ... meeting, which will take place April 22-28, 2017, in ... will present four abstracts at AAN, including safety and ... and factors associated with a reduction in monthly migraine ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):